Approval · Notice of Compliance 36327 · 2025
ORGOVYX: Notice of Compliance 36327
Issued November 5, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36327
- Date
- November 5, 2025
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGOVYX | 02542137 | Marketed |
Medicinal ingredients
- RELUGOLIX 120 MG per TAB